Xu, J., Li, Z., Tong, Q., Zhang, S., Fang, J., Wu, A., . . . Lu, W. CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma. Nature Portfolio.
Chicago Style (17th ed.) CitationXu, Jiaojiao, et al. CD133+PD-L1+ Cancer Cells Confer Resistance to Adoptively Transferred Engineered Macrophage-based Therapy in Melanoma. Nature Portfolio.
MLA (9th ed.) CitationXu, Jiaojiao, et al. CD133+PD-L1+ Cancer Cells Confer Resistance to Adoptively Transferred Engineered Macrophage-based Therapy in Melanoma. Nature Portfolio.
Warning: These citations may not always be 100% accurate.